Initially, we were involved in contract manufacturing of pharmaceuticals and medicines, technology development, and as experts in the development of several pharmaceuticals and pharmaceutical products.
1995
January 1st - Establishment of MEDITOP Pharmaceuticals Ltd.
Obtaining a pharmaceutical manufacturing licence for the production of solid dosage forms
Establishment of our own R&D department
Launch of the first non-prescription products (Mycosid, Betacid, Optacid, Hyperol)
1996
First international partner (Novartis)
1998
Registration of the first in house development prescription products.
2002
Launch of Nasopax nasal spray, the company's first supergeneric product.
2007
First international registration (Tolperisone in Germany).
2011
Establishment of a representative office in Vietnam
2014
Construction of a new factory and office complex - tripling the production area.
2020
Purchase of brand new state-of-the-art equipment at a cost of around €6 million.
2021
The most intensive international expansion in the company's history. Registration of more than 100 products in several countries in Europe and Asia.
Winner of the 2021 Hungarian Innovation Grand Prize.
2022
New generic antiepileptic developed and registered in 6 EU countries. Obtain patent for manufacturing process.
Establishment of a Swiss subsidiary.
2023
Opening of an Uzbek representative office.